Accommodating intraocular lenses and methods of use

Information

  • Patent Grant
  • 11751991
  • Patent Number
    11,751,991
  • Date Filed
    Tuesday, October 20, 2020
    4 years ago
  • Date Issued
    Tuesday, September 12, 2023
    a year ago
Abstract
Accommodating intraocular lenses containing a flowable media and their methods of accommodation.
Description
BACKGROUND

Cataracts are a major cause of blindness in the world and the most prevalent ocular disease. When the disability from cataracts affects or alters an individual's activities of daily living, surgical lens removal with intraocular lens (“IOL”) implantation is the preferred method of treating the functional limitations.


A cataract is any opacity of a patient's lens, whether it is a localized opacity or a diffuse general loss of transparency. To be clinically significant, however, the cataract must cause a significant reduction in visual acuity or a functional impairment. A cataract occurs as a result of aging or secondary to hereditary factors, trauma, inflammation, metabolic or nutritional disorders, or radiation. Age related cataract conditions are the most common.


In treating a cataract, the surgeon removes the crystalline lens matrix from the lens capsule and replaces it with an IOL. The typical IOL provides a selected focal length that allows the patient to have fairly good distance vision. Since the lens can no longer accommodate, however, the patient typically needs glasses for reading.


More specifically, the imaging properties of the human eye are facilitated by several optical interfaces. A healthy youthful human eye has a total power of approximately 59 diopters, with the anterior surface of the cornea (e.g. the exterior surface, including the tear layer) providing about 48 diopters of power, while the posterior surface provides about −4 diopters. The crystalline lens, which is situated posterior of the pupil in a transparent elastic capsule, also referred to herein as “capsular sac,” supported by the ciliary muscles via zonules, provides about 15 diopters of power, and also performs the critical function of focusing images upon the retina. This focusing ability, referred to as “accommodation,” enables imaging of objects at various distances.


The power of the lens in a youthful eye can be adjusted from 15 diopters to about 29 diopters by adjusting the shape of the lens from a moderately convex shape to a highly convex shape. The mechanism generally accepted to cause this adjustment is that ciliary muscles supporting the capsule (and the lens contained therein) move between a relaxed state (corresponding to the moderately convex shape) and a contracted state (corresponding to the highly convex shape). Because the lens itself is composed of viscous, gelatinous transparent fibers, arranged in an “onion-like” layered structure, forces applied to the capsule by the ciliary muscles via the zonules cause the lens to change shape.


Isolated from the eye, the relaxed capsule and lens take on a more spherical shape. Within the eye, however, the capsule is connected around its circumference by approximately 70 tiny ligament fibers to the ciliary muscles, which in turn are attached to an inner surface of the eyeball. The ciliary muscles that support the lens and capsule therefore are believed to act in a sphincter-muscular mode. Accordingly, when the ciliary muscles are relaxed, the capsule and lens are pulled about the circumference to a larger diameter, thereby flattening the lens, whereas when the ciliary muscles are contracted the lens and capsule relax somewhat and assume a smaller diameter that approaches a more spherical shape.


As noted above, the youthful eye has approximately 14 diopters of accommodation. As a person ages, the lens hardens and becomes less elastic, so that by about age 45-50, accommodation is reduced to about 2 diopters. At a later age the lens may be considered to be non-accommodating, a condition known as “presbyopia”. Because the imaging distance is fixed, presbyopia typically entails the need for bi-focals to facilitate near and far vision.


Apart from age-related loss of accommodation ability, such loss is innate to the placement of IOLs for the treatment of cataracts. IOLs are generally single element lenses made from a suitable polymer material, such as acrylics or silicones. After placement, accommodation is no longer possible, although this ability is typically already lost for persons receiving an IOL. There is significant need to provide for accommodation in IOL products so that IOL recipients will have accommodating ability.


Although efforts have been made with accommodating IOLs, there is a need for an accommodating IOL that can restore as much accommodation to the eye as possible.


SUMMARY OF THE DISCLOSURE

One aspect of the invention is an accommodating intraocular lens. The lens includes an optic portion comprising an anterior element, a posterior element, and an intermediate layer disposed along an optical path of the lens, wherein the intermediate layer is disposed between the anterior element and the posterior element. The lens also includes a peripheral portion in fluid communication with the optic portion. The intraocular lens is adapted such that when a flowable media is moved between the peripheral portion and the optic portion in response to ciliary muscle movement, at least two of the anterior element, the posterior element, and the intermediate layer move from a first configuration to a second configuration.


In some embodiments the posterior element comprises a channel formed therein, and wherein the posterior element and the intermediate layer define an active channel in fluid communication with the peripheral portion. The anterior element can be bonded to the intermediate layer, such as along the periphery of the anterior layer. The intermediate layer can also be bonded to the posterior element.


In some embodiments the intermediate layer comprises an actuator. The actuator can be in contact with the anterior element throughout an entire accommodation range of the intraocular lens, or the actuator may not be in contact with the anterior element throughout an entire accommodation range of the intraocular lens. The actuator assumes a substantially conical configuration in a disaccommodated configuration.


In some embodiments the peripheral portion is coupled to the posterior element. The posterior element can include a buttress element disposed at the periphery of the posterior element, and wherein the peripheral portion is coupled to the buttress element. The peripheral portion can comprises a haptic and the haptic comprises a connection element adapted to fit within a bore in the buttress element. The peripheral portion can comprise a haptic and the buttress element comprises a connection element adapted to fit within a bore in the haptic.


In some embodiments the intermediate layer and the anterior element define a passive chamber containing a second flowable media therein. The anterior element, the intermediate layer, the posterior element, the second flowable media, and the flowable media can all be substantially indexed matched to one another.


In some embodiments the at least two of the anterior element, the posterior element, and the intermediate layer that move from a first configuration to a second configuration are the intermediate layer and the anterior element.


One aspect of the invention is an accommodating intraocular lens. The lens includes an optic portion comprising an anterior element, a posterior element, and an intermediate layer disposed between the anterior element and the posterior element. An anterior surface of the anterior element defines an anterior surface of the lens and a posterior surface of the posterior element defines a posterior surface of the lens. The lens also includes a peripheral portion in fluid communication with the optic portion. The intraocular lens is adapted such that when a flowable media is moved between the optic portion and the peripheral portion in response to ciliary muscle movement, at least one of the anterior surface of the lens and the posterior surface of the lens moves from a first configuration to a second configuration.


In some embodiments a first surface of the intermediate layer partially defines an active channel which is in fluid communication with the peripheral portion. The intermediate layer and the posterior element can define the active channel. The intermediate layer and the anterior element can define a passive chamber containing a second flowable media. In some embodiments the anterior element, the posterior element, the intermediate layer, the flowable media, and the second flowable media all are substantially index-matched to each other.


In some embodiments the anterior element is bonded to the intermediate layer, which can be along the periphery of the anterior layer. The intermediate layer can be bonded to the posterior element.


In some embodiments the intermediate layer comprises an actuator, which can be in contact with the anterior element throughout an entire accommodation range of the intraocular lens, or which can be in contact with the anterior element only through a portion of an entire accommodation range of the intraocular lens. The actuator can assume a substantially conical configuration in a disaccommodated configuration.


In some embodiments the peripheral portion is coupled to the posterior element. The posterior element can include a buttress element disposed at the periphery of the posterior element, and the peripheral portion is coupled to the buttress element. The peripheral portion can comprises a haptic and the haptic comprises a connection element adapted to fit within a bore in the buttress element. The buttress element can alternatively comprise a connection element adapted to fit within a bore in the haptic.


One aspect of the invention is a method of changing an optical parameter of an accommodating intraocular lens. The method includes providing an intraocular lens comprising an optic portion and a peripheral portion extending peripherally from the optic portion, wherein the optic portion comprises an anterior element, a posterior element, and an intermediate layer disposed between the anterior element and the posterior element. The optic portion and the peripheral portion are in fluid communication. The method also includes moving a flowable media between the optic portion and the peripheral portion in response to ciliary muscle movement to change an optical parameter of the intraocular lens, wherein moving a flowable media between the optic portion and the peripheral portion comprises moving at least two of the anterior element, the intermediate layer, and the posterior element from a first configuration to a second configuration.


In some embodiments moving a flowable media between the optic portion and the peripheral portion comprises deforming the peripheral portion. Moving at least two of the anterior element, the intermediate layer, and the posterior element can comprise moving the intermediate layer and the anterior element from a first configuration to a second configuration.


In some embodiments the intermediate layer and the posterior element define an active channel in fluid communication with the peripheral portion, and the intermediate layer and the anterior element define a passive chamber containing a second flowable media therein. The method further comprising index matching the anterior element, the intermediate layer, the posterior element, the second flowable media, and the flowable media.


One aspect of the invention is a method of changing the power of an accommodating intraocular lens. The method includes providing an intraocular lens including an optic portion and a non-optic peripheral portion, wherein the optic portion comprises an anterior element, a posterior element, and an intermediate layer disposed between the anterior element and the posterior element, and wherein an anterior surface of the anterior element defines an anterior surface of the intraocular lens, and wherein a posterior surface of the posterior element defines a posterior surface of the intraocular lens. The method also includes moving a flowable media between the optic portion and the non-optic portion in response to ciliary muscle movement to change the power of the intraocular lens, wherein moving a flowable media between the optic portion and the non-optic portion comprises moving at least one of the anterior surface of the intraocular lens and the posterior surface of the intraocular lens.


In some embodiments moving a flowable media between the optic portion and the non-optic portion comprises deforming the non-optic portion. Moving a flowable media between the optic portion and the non-optic portion can comprise moving the intermediate layer from a first configuration to a second configuration.


In some embodiments the intermediate layer and the posterior element define an active channel in fluid communication with the peripheral portion, and the intermediate layer and the anterior element define a passive chamber containing a second flowable media therein. The method also includes index matching the anterior element, the intermediate layer, the posterior element, the second flowable media, and the flowable media.


INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIGS. 1, 2A, and 2B illustrate the structure and operation of a human eye.



FIGS. 3-5 show an exemplary embodiment of an intraocular lens.



FIG. 6 shows a portion of an exemplary intraocular lens in disaccommodative and accommodative configurations.



FIG. 7 shows an exemplary optic portion of an intraocular lens.



FIGS. 8A-8C show an alternative embodiment of an intraocular lens.



FIGS. 9-12 show an alternative embodiment of an intraocular lens.



FIGS. 13-15 show an alternative embodiment of an intraocular lens in varying accommodative configurations.



FIG. 16 shows an exemplary haptic being compressed between a lens capsule and an optic portion.



FIGS. 17-20 show exemplary alternative haptic designs.



FIG. 21 illustrates dimensions of an exemplary haptic.



FIG. 22 shows an exemplary haptic design and a capsule in accommodated and disaccommodated configurations.



FIGS. 23 and 24 show an alternative haptic design comprising bellows.





DETAILED DESCRIPTION

The invention relates generally to intraocular lenses (“IOLs”) and particularly to accommodating intraocular lenses. In preferred embodiments the IOL includes a flowable media (such as a fluid, gelatinous material, etc.) that is moved within the IOL, in response to ciliary muscle movement, to change the power of the IOL.



FIGS. 1 and 2 illustrate the structure and operation of a human eye. Eye 100 includes cornea 1, iris 2, ciliary muscles 3, ligament fibers or zonules 4, capsule 5, lens 6 and retina 7. Natural lens 6 is composed of viscous, gelatinous transparent fibers, arranged in an “onion-like” layered structure, and is disposed in transparent elastic capsule 5. Capsule 5 is joined by zonules 4 around its circumference to ciliary muscles 3, which are in turn attached to the inner surface of eye 0. Vitreous 8 is a highly viscous, transparent fluid that fills the center of eye 100.


Isolated from the eye, the relaxed capsule and lens take on a convex shape. However, when suspended within the eye by zonules 4, capsule 5 moves between a moderately convex shape (when the ciliary muscles are relaxed) and a highly convex shape (when the ciliary muscles are contracted). As shown in FIG. 2A, when ciliary muscles 3 relax, capsule 5 and lens 6 are pulled about the circumference, thereby flattening the lens. As shown in FIG. 2B, when ciliary muscles 3 contract, capsule 5 and lens 6 relax and become thicker. This allows the lens and capsule to assume a more convex shape, thus increasing the diopter power of the lens.


Additionally, various natural mechanisms affect the design requirements of the present invention. For example, during accommodation the pupil naturally stops down (i.e., reduces in diameter) which reduces the area of the natural lens that transmits light. In addition, the eye will experience the Stiles-Crawford Effect which also reduces the effective area of the natural lens. In particular, the brightness of light rays incident on cones in the eye is dependent on the angle at which those rays are incident on the cones. In particular, light rays that strike the cones perpendicular to their surface appear brighter than those that do not. As a result, the light rays passing through the periphery of the lens are less significant for proper vision.



FIGS. 3-5 show a first embodiment of accommodating IOL 10. IOL 10 includes a peripheral non-optic portion comprising haptics 12 and 14. The IOL also includes an optic portion including anterior lens element 16, intermediate layer 18 which comprises actuator 20, and substrate, or posterior element, 22. Anterior element 16 is bonded to intermediate layer 18 at its periphery. In some embodiments the anterior element may also be bonded to actuator 20. The intermediate layer is also bonded to posterior element 22. The inner surface of haptics 12 and 14 define interior volumes 24 which are in fluid communication with active channel 26 defined by posterior element 22 and intermediate layer 18. As shown, actuator 20 is integral with intermediate layer 18. Posterior element 22 is molded with buttresses 11 which include a buttress bore 13 therethrough. The haptics have a haptic attachment element 15 (which can be stiff or flexible) which is sized and shaped to fit within buttress bore 13. An adhesive layer can be applied to the outer surfaces of the haptic attachment elements and/or the inner surface of the buttress bore to facilitate attachment of the haptics to the optic portion. The IOL contains a flowable media within the haptics and the active channel. The IOL also includes passive chamber 21 that is defined by the anterior element and the intermediate layer. The passive chamber contains a second flowable media (e.g., a fluid, elastomer, etc.), which may be the same as the fluid within the haptics and active channel, or it may be a different flowable media. The active channel and the passive chamber are not in fluid communication.


Deformation of haptics 12 and 14 in response to contraction of ciliary muscles movement transfers the flowable media (such as a fluid) between interior volume 24 and active channel 26. When the flowable media is transferred into the active channel from the haptics, the pressure in the active channel increases, causing actuator 20 to deflect in the anterior direction. This causes anterior element 16 to deflect in the anterior direction, increasing the IOL power in this accommodated configuration.


In any of the embodiments herein, moving fluid between the haptics and the optic portion can cause the change in curvature of the posterior element rather than, or in addition to, the anterior element. While changing the curvature of the anterior element is described herein, this is not meant to be limiting to the IOLs. For example, the IOL can be flipped upon implantation such that the anterior element is disposed on the posterior side of the lens, while the posterior element is disposed on the anterior side of the lens. Moving fluid from the haptics to the optics would therefore cause the posterior surface of the IOL deflect. Alternatively, the actuator can be in contact with the posterior element and the active channel can be defined by the intermediate layer and the anterior element, while the passive chamber is defined by the posterior element and the intermediate layer. Moving fluid from the haptics to the active channel would thereby deflect the posterior element.



FIG. 6 is a cross sectional view of a section of an exemplary IOL showing the IOL in a disaccommodated state (dashed lines) and an accommodated state (solid lines). The IOL includes anterior element 74, intermediate layer 78 which includes actuator 73, and posterior element 75. Actuator 73 is comprised of deflection element 71 and bellows 70. When the pressure is increased in active channel 72, bellows 70 change configuration from the generally conical shape of the disaccommodated state to a curvilinear configuration of the accommodated state. Deflection element 71 is forced in the anterior direction due to the increase in pressure. This causes anterior element 74 to deflect in the anterior direction as well, steepening the curvature of the anterior element and thereby increasing the power of the lens.


All of the components of the optic portion, including the active flowable media and the passive flowable media, can be substantially index-matched to provide for a generally singular lens element defined by the anterior surface of the anterior element and the posterior surface of the posterior element. “Substantially index-matched” as used herein refers to an IOL whose components are intended to have the same index of refraction, but whose actual indices may differ slightly. The term also refers to a lens which can have adhesive (to bond different components of the lens together) which may have an index of refraction that is slightly different than the indices of the other IOL components.


Some of the components may, however, have different indices of refraction, creating additional interfaces within the IOL.



FIG. 7 is a cross sectional view of an IOL (haptics not shown) similar to that shown in FIGS. 3-5. FIG. 7 illustrates exemplary dimensions of the optic portion of the IOL. Anterior element diameter 30 is about 6.0 mm. The anterior element thickness 31 at the center of the anterior element is about 0.43 mm. Intermediate layer edge thickness 32 is about 0.35 mm. Intermediate layer center thickness 33 (i.e., deflection element center thickness) is about 0.63 mm. Bellows length 40 is about 1.0 mm. Bellows thickness 34 is about 0.10 mm. Actuator diameter 35 is about 3.40 mm. Posterior element edge thickness 36 is about 0.60 mm. Posterior element center thickness 37 is about 0.70 mm. Posterior element diameter 38 can be about 6.6 mm to about 7.4 mm. The IOL center thickness 39 (in the disaccommodated configuration) between the anterior surface of the anterior element and posterior surface of the posterior element along the optical axis of the lens is about 1.8 mm to about 2.2 mm.


Bellows thickness 34 can be adjusted to change the responsiveness of the actuator. As the thickness of the bellows decreases, less fluid pressure is generally required to displace the actuator. In some embodiments the bellows thickness is between about 0.05 mm and about 0.3 mm.


Decreasing the anterior element thickness 31 generally increases the responsiveness of the actuator for a given fluid pressure. Length of bellows 40 can also be adjusted to alter the responsiveness of the actuator (actuator diameter 35 can similarly be adjusted). As the length of the bellows increases, the volume of the active channel is increased and more volume of flowable media is required to move the actuator. However, by increasing the bellows length, the pressure in the active channel is decreased. Therefore, the volume and pressure required to drive the actuator can be optimized in combination with the flowable media transferred from the haptics to provide the greatest response.


In some embodiments the length of the bellows is between about 1 mm and 2 mm. In some embodiments actuator diameter 35 is between about 2.8 mm and about 4.2 mm.


The dimensions given above are merely exemplary and not intended to be limiting.



FIGS. 8A-8C show an additional embodiment of IOL 401. IOL 401 includes anterior element 404, intermediate layer 402, posterior element 400, and haptics 412. Intermediate layer 402 comprises an actuator, which comprises deflection element 406 and bellows 408. Also shown are passive chamber 405 and active channel 410. As can be seen in FIGS. 8B and 8C, anterior element 404 and intermediate layer 402 are bonded directly to posterior element 400, which removes an intermediate assembly step of coupling the intermediate layer 402 to the anterior element 404 (as is the construction in the embodiment shown in FIGS. 3-5). Anterior element 404 and intermediate layer 402 are both bonded to posterior element 400 along their periphery. Anterior element 404 is bonded to posterior element 400 at a location more radially outward from the optical axis OA than is intermediate layer 402.


The amount of shape change (i.e., the change in curvature) that the anterior element will undergo in response to fluid movement between the peripheral portion and the optic portion will depend partially on how and where the anterior element is bonded to either the intermediate layer or the posterior element. By varying these boundary conditions it is possible to change the optic power shift for a given amount of displacement at the center of the lens. For example, an anterior element bonded at the very edge of its periphery will deflect in a more spherical manner than will an anterior element that is bonded more radially inward than merely at its periphery. The former is allowed to flex all the way out to its periphery, while the latter is more constrained when deflected and will assume a less spherical configuration when in an accommodated configuration (i.e., will have a stronger aberration).


In addition, the lens bonded at its periphery will deflect at lower active channel pressures than will a lens that is bonded closer to the center.


The anterior element is attached to the posterior element at surface 417 of the posterior element. This mating surface is substantially orthogonal to the optical axis OA. This helps with the assembly process, and gives anterior element 404 a firm foundation on which to sit. FIG. 8C shows a cross sectional perspective view including haptics 412.


The posterior element in FIG. 8A includes buttresses 411. Buttresses 411 include nipples 413 which are adapted to fit within haptic bore 415 to attach the haptics to the posterior element. Adhesive can be applied to the mating surfaces.



FIGS. 9-12 show an alternative embodiment of IOL 200. IOL 200 includes anterior element 202, intermediate layer 204, posterior element 206, and haptics 208. The haptics are attached to the intermediate layer 204 by attaching buttress elements 212 with optic buttresses 210. The actuator includes deflection element 213 and bellows 215. FIG. 12 is a top view showing the haptics (optic portion not shown). As can be seen, haptic buttress element 212 is incorporated into haptic 208 and attaches to the optic portion at optic buttress 210. One difference in this embodiment is that most of the mechanical complexity is incorporated into one component of the lens—the intermediate layer. Because the haptics incorporate a buttress element, the change in direction (roughly 90 degrees) of the flowable media occurs in the haptic buttress element rather than in an optic buttress as is the case in the embodiments shown in FIGS. 3-5 and FIGS. 8A-8C.



FIGS. 13-15 illustrate an alternative embodiment in which deflection element 312 of the intermediate layer is not in contact with anterior element 302 during the entire accommodation motion of the lens. FIG. 13 shows IOL 300 in a disaccommodated state including anterior element 302, intermediate layer 304 (including deflection element 312 of the actuator), and posterior element 306. The IOL includes gap 310 between the deflection element and the anterior element. When there is no pressure in active channel 308 or in passive chamber 314 (as shown in FIG. 13), the geometry and passive fluid state is such that there is gap 310 between the deflection element and the anterior element.


As the pressure in active channel 308 increases (due to movement of the capsular bag), deflection element 312 moves in the anterior direction. Because of the pressure transfer into passive chamber 314, anterior element 302 also moves in the anterior direction (thus increasing the power of the lens) but remains generally spherical. The deflection element deflects more quickly than the anterior element, until they engage, as shown in FIG. 14.


As the pressure in the active channel continues to increase, the actuator continues to deflect in the anterior direction. Because the deflection element is in contact with the anterior element, further deflection element movement deflects the anterior element. Because of the size of the deflection element relative to the anterior element, the fluid in passive chamber 314 redistributes and creates an aspheric effect in anterior element 302, as shown in FIG. 15. This further increases the power of the IOL for a smaller aperture.


This embodiment allows for a lower power change rate at relatively low stimulus levels (FIG. 14) and a higher power change rate at higher stimulus levels (FIG. 15). The anterior element can remain generally spherical when under a low stimulus and becomes aspherical when under a higher stimulus.


One or more of the optic components can be made from suitable polymeric materials. In one embodiment all of the optic components are made of substantially the same polymeric material. Exemplary polymeric compositions that can be used for the optic portion include those described in commonly owned, co-pending U.S. patent application Ser. No. 12/034,942, filed Feb. 21, 2008, and U.S. patent application Ser. No. 12/177,720, filed Jul. 22, 2008.


The haptics are disposed on the lens such that when implanted in the lens capsule, the haptics deform in response to the capsule shape changes. The capsule changes shape as the zonules apply or relax forces on the capsule in response to ciliary muscle relaxation or contraction.


In one embodiment the IOL is a fluid-driven accommodating IOL which is adapted to move fluid between an interior chamber in the haptics and the optic portion in response to ciliary muscle movement to cause a change in the power of the lens. In a particular embodiment the fluid is moved to the optic portion as the ciliary muscles begin to contract, causing the zonules to relax the forces applied to the capsule. As the zonules relax the forces, the capsule and/or the optic portion compress the haptic, resulting in fluid moving to the optic portion and an increase in fluid pressure in the optic portion. The fluid movement causes a deflection in an anterior element of the lens, which increases the power of the lens.



FIG. 16 shows the cross sections of an exemplary haptic 50 being compressed between the lens capsule 52 and the optic portion 54 by compressive force “B”. Because the fluid is moved between the haptic and optic portion as the haptic is compressed, the responsiveness of the haptic to the change in forces from the capsule is important in creating an energy efficient IOL. It is generally desirable to transfer energy as efficiently as possible from the forces applied or relaxed on the capsule to the anterior element displacement. The overall shape of the haptic, and perhaps more importantly, the cross-sectional shape of the haptic, can influence how efficiently fluid is transferred between the haptic and the optic portion in response to ciliary muscle relaxation/contraction. It is desirable to obtain a greater response from the haptic in response to a change in force on the lens capsule. It is also desirable to have a haptic/lens system that responds quickly to changes in capsule state.



FIGS. 17-20 show exemplary haptic shapes and cross sections. FIG. 17 shows a haptic with an elliptical cross section, with a height H greater than width W. FIG. 18 shows a haptic with a “D” shaped cross section. FIG. 19 shows an alternative haptic shape with a circular cross section. FIG. 20 illustrates a haptic with a flat oval cross section.


Other shapes and/or cross sections can also be used to provide for a more responsive haptic. In addition, the haptic may be comprised of a plurality of sections each with differing polymeric compositions, which may allow one section of the haptic to be stiffer than a different section, which could help increase the responsiveness of the haptic. Exemplary polymeric compositions that can be used for the haptics include those described in U.S. patent application Ser. No. 12/034,942, filed Feb. 21, 2008, and U.S. patent application Ser. No. 12/177,720, filed Jul. 22, 2008.


Wall thicknesses can also be varied in a given cross-section to allow localized movement and to increase efficiency. FIG. 21 is a cross sectional view showing the exemplary cross section of a haptic. Haptic height 260 is between about 3.0 mm and about 3.4 mm. Haptic width 262 is between about 1.2 mm and about 2.0 mm. Haptic wall thickness 264 is between about 0.1 mm and about 0.3 mm. These dimensions are merely exemplary and are not intended to be limiting.


In some embodiments the haptic shape may be adapted to more naturally mate with the curved equatorial portion of the lens capsule in an disaccommodated state, or to better compliment the corresponding mating surface of the lens. This may help increase the responsiveness of the haptic and decrease the amount of lost movement due to “dead space” between the haptic and the capsule. FIG. 19 is an example of this. FIG. 22 shows an additional cross sectional design of haptic 300, in addition to the capsule in accommodated and disaccommodated configurations.



FIG. 23 shows an alternative haptic design comprising bellows 501 along one side of haptic 500. The haptic can be attached to the optic portion using any of the methods described or referenced herein. Haptic 500 can also include a reinforcing element 502 along the peripheral side of the haptic to ensure the haptic contacts the capsule bag equator. The reinforcing element can be, for example, a reinforced nitinol wire (metal) or monofilament (plastic).



FIG. 24 is a top view showing IOL 512 in a disaccommodated state (natural relaxed state) before implantation relative to exemplary capsular bag 506. Haptics 500 have a diameter of about 10 mm. The optic portion has a diameter of about 6 mm. When implanted in the capsular bag, the capsular bag relaxation causes pressure to be exerted on the haptics, thus bending the haptics. The bellows provide for greater volume reduction in the haptics, which displaces more volume of fluid to the optic portion.


Additional exemplary accommodating IOLs that can incorporate any of the features described herein are described in commonly owned U.S. Provisional Application No. 60/433,046, filed Dec. 12, 2002; U.S. Pat. Nos. 7,122,053; 7,261,737; 7,247,168; and 7,217,288; U.S. patent application Ser. No. 11/642,388, filed Dec. 19, 2006; and U.S. patent application Ser. No. 11/646,913, filed Dec. 27, 2006, the disclosures of which are hereby incorporated by reference in their entirety.


While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Claims
  • 1. An ophthalmic device, comprising: an optic portion comprising an anterior optic surface, a posterior optic surface, and an optic fluid chamber, wherein the optic fluid chamber comprises a chamber opening projecting radially outward from a lateral side of the optic portion;a peripheral portion coupled to the optic portion at the chamber opening;wherein the ophthalmic device is configured to be implanted within a capsular bag of a subject,wherein the peripheral portion comprises an interior volume filled with a fluid,wherein the interior volume is in fluid communication with the optic fluid chamber,wherein the anterior optic surface is configured to deform in response to a deformation of the peripheral portion due to capsular bag reshaping initiated by ciliary muscle movement undertaken by the subject, andwherein a segment of the peripheral portion comprises a radially outer peripheral wall and a radially inner peripheral wall closer to the optic portion than the radially outer peripheral wall, wherein a cross-sectional profile of the radially outer peripheral wall is curved radially outward away from the optic portion.
  • 2. The ophthalmic device of claim 1, wherein the peripheral portion surrounds a circular arc of part of a circumference of the optic portion.
  • 3. The ophthalmic device of claim 1, wherein the interior volume is a volume of a peripheral fluid chamber, wherein the peripheral fluid chamber has a proximal opening, wherein the proximal opening interfaces with the chamber opening when the peripheral portion is coupled to the optic portion, wherein a segment of the peripheral fluid chamber surrounds a circumferential segment of the optic portion.
  • 4. The ophthalmic device of claim 3, wherein the anterior optic surface is configured to deform in response to a displacement of fluid from the peripheral fluid chamber to the optic fluid chamber in response to the deformation of the peripheral portion.
  • 5. The ophthalmic device of claim 1, wherein a power of the ophthalmic device is configured to change in response to the deformation of the anterior optic surface.
  • 6. The ophthalmic device of claim 1, wherein the peripheral portion is made in part of a flexible polymeric material.
  • 7. The ophthalmic device of claim 1, wherein the peripheral portion comprises an anterior-most portion, and wherein at least part of the anterior optic surface is disposed posterior to the anterior-most portion of the peripheral portion.
  • 8. The ophthalmic device of claim 1, wherein a cross-sectional profile of the peripheral portion at one segment of the peripheral portion is D-shaped.
  • 9. An ophthalmic device, comprising: an optic portion with a deformable anterior surface, a posterior surface, and a fluid chamber adapted to house a fluid therein, wherein the optic fluid chamber comprises a chamber opening projecting radially outward from a lateral side of the optic portion; anda peripheral portion coupled to the optic portion at the chamber opening,wherein the ophthalmic device is configured to be implanted within a capsular bag of a subject,wherein the peripheral portion is configured to curve radially outward and engage with a curved equatorial portion of the capsular bag, andwherein the deformable anterior surface of the optic portion is configured to deform in response to a deformation of the peripheral portion due to capsular bag reshaping initiated by ciliary muscle movement undertaken by the subject.
  • 10. The ophthalmic device of claim 9, wherein a power of the optic portion is configured to change in response to the deformation of the deformable anterior surface.
  • 11. The ophthalmic device of claim 9, wherein the peripheral portion surrounds a circular arc of part of a circumference of the optic portion.
  • 12. The ophthalmic device of claim 9, wherein the peripheral portion comprises an anterior-most portion, and wherein at least part of the deformable anterior surface is disposed posterior to the anterior-most portion of the peripheral portion.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/860,459, filed Jan. 2, 2018, which is a continuation of U.S. application Ser. No. 13/711,552, filed Dec. 11, 2012, now U.S. Pat. No. 9,855,137, which is a continuation of U.S. application Ser. No. 12/177,857, filed Jul. 22, 2008, now U.S. Pat. No. 8,328,869, which claims the benefit of U.S. Provisional Application No. 60/951,441, filed Jul. 23, 2007; U.S. application Ser. No. 12/177,857 is a continuation-in-part of U.S. application Ser. No. 11/646,913, filed Dec. 27, 2006, now U.S. Pat. No. 7,637,947, and is a continuation-in-part of U.S. application Ser. No. 11/782,474, filed Jul. 24, 2007, now abandoned, which is a continuation of U.S. Ser. No. 11/173,961, filed Jul. 1, 2005, now U.S. Pat. No. 7,247,168, each of which is hereby incorporated herein by reference in its entirety.

US Referenced Citations (493)
Number Name Date Kind
4111995 Nelson Sep 1978 A
4251887 Anis Feb 1981 A
4253199 Banko Mar 1981 A
4254509 Tennant Mar 1981 A
4304895 Loshaek Dec 1981 A
4373218 Schachar Feb 1983 A
4409691 Levy Oct 1983 A
4423809 Mazzocco Jan 1984 A
4435855 Pannu Mar 1984 A
4435856 L'esperance Mar 1984 A
4466705 Michelson Aug 1984 A
4490860 Rainin Jan 1985 A
4494254 Lopez Jan 1985 A
4512040 Mcclure Apr 1985 A
4528311 Beard et al. Jul 1985 A
4575373 Johnson Mar 1986 A
4585457 Kalb Apr 1986 A
4604295 Humphreys Aug 1986 A
4615701 Woods Oct 1986 A
4620954 Singer et al. Nov 1986 A
4685921 Peyman Aug 1987 A
4685922 Peyman Aug 1987 A
4693717 Michelson Sep 1987 A
4720286 Bailey et al. Jan 1988 A
4731078 Stoy et al. Mar 1988 A
4731079 Stoy Mar 1988 A
4731080 Galin Mar 1988 A
4764423 Yamaguchi et al. Aug 1988 A
4784485 Ho Nov 1988 A
4787903 Grendahl Nov 1988 A
4790847 Woods Dec 1988 A
4813956 Gupta Mar 1989 A
4816031 Pfoff Mar 1989 A
4836201 Patton et al. Jun 1989 A
4842601 Smith Jun 1989 A
4848343 Wallsten et al. Jul 1989 A
4888012 Horn et al. Dec 1989 A
4892543 Turley Jan 1990 A
4902293 Feaster Feb 1990 A
4913536 Barnea Apr 1990 A
4919151 Grubbs et al. Apr 1990 A
4932966 Christie et al. Jun 1990 A
4946469 Sarfarazi Aug 1990 A
4950289 Krasner Aug 1990 A
4963148 Sulc et al. Oct 1990 A
4994082 Richards et al. Feb 1991 A
4995879 Dougherty Feb 1991 A
4995880 Galib Feb 1991 A
5015254 Greite May 1991 A
5035710 Nakada et al. Jul 1991 A
5047051 Cumming Sep 1991 A
5061914 Busch et al. Oct 1991 A
5066301 Wiley Nov 1991 A
5078740 Walman Jan 1992 A
5145884 Yamamoto et al. Sep 1992 A
5145935 Hayashi Sep 1992 A
5152789 Willis Oct 1992 A
5169920 Okawa Dec 1992 A
5171266 Wiley et al. Dec 1992 A
5200430 Federman Apr 1993 A
5201763 Brady et al. Apr 1993 A
5203788 Wiley Apr 1993 A
5213579 Yamada et al. May 1993 A
5224957 Gasser et al. Jul 1993 A
5235003 Ward et al. Aug 1993 A
5251993 Sigourney Oct 1993 A
5275623 Sarfarazi Jan 1994 A
5275624 Hara et al. Jan 1994 A
5288293 O'donnell Feb 1994 A
5290892 Namdaran et al. Mar 1994 A
5326347 Cumming Jul 1994 A
5391590 Gerace et al. Feb 1995 A
5405386 Rheinish et al. Apr 1995 A
5426166 Usifer et al. Jun 1995 A
5443506 Garabet Aug 1995 A
5444106 Zhou et al. Aug 1995 A
5444135 Cheradame et al. Aug 1995 A
5476514 Cumming Dec 1995 A
5489302 Skottun Feb 1996 A
5496366 Cumming Mar 1996 A
5506300 Ward et al. Apr 1996 A
5512609 Yang Apr 1996 A
5567365 Weinschenk et al. Oct 1996 A
5578081 Mcdonald Nov 1996 A
5585049 Grisoni et al. Dec 1996 A
5593436 Langerman Jan 1997 A
5607472 Thompson Mar 1997 A
5628795 Langerman May 1997 A
5633504 Collins et al. May 1997 A
5665822 Bitler et al. Sep 1997 A
5674282 Cumming Oct 1997 A
5676669 Colvard Oct 1997 A
5693095 Freeman et al. Dec 1997 A
5697973 Peyman et al. Dec 1997 A
5702441 Zhou Dec 1997 A
5767669 Hansen et al. Jun 1998 A
5774273 Bornhorst Jun 1998 A
5776191 Mazzocco Jul 1998 A
5776192 Mcdonald Jul 1998 A
5800533 Eggleston et al. Sep 1998 A
5814680 Imafuku et al. Sep 1998 A
5843188 Mcdonald Dec 1998 A
5891931 Leboeuf et al. Apr 1999 A
5928282 Nigam Jul 1999 A
5964802 Anello et al. Oct 1999 A
5968095 Norrby Oct 1999 A
5984962 Anello et al. Nov 1999 A
6013101 Israel Jan 2000 A
6015842 Leboeuf et al. Jan 2000 A
6102539 Tucker Aug 2000 A
6117171 Skottun Sep 2000 A
6124980 Cerbell Sep 2000 A
6139576 Doyle et al. Oct 2000 A
6160084 Langer et al. Dec 2000 A
6176878 Gwon et al. Jan 2001 B1
6180687 Hammer et al. Jan 2001 B1
6188526 Sasaya et al. Feb 2001 B1
6190410 Lamielle et al. Feb 2001 B1
6195807 Chou Mar 2001 B1
6197059 Cumming Mar 2001 B1
6217612 Woods Apr 2001 B1
6225367 Chaouk et al. May 2001 B1
6229611 Hung May 2001 B1
6229641 Kosaka May 2001 B1
6299641 Woods Oct 2001 B1
6302911 Hanna Oct 2001 B1
6322589 Cumming Nov 2001 B1
6342073 Cumming et al. Jan 2002 B1
6348437 Avery et al. Feb 2002 B1
6387126 Cumming May 2002 B1
6388043 Langer et al. May 2002 B1
6406494 Laguette et al. Jun 2002 B1
6413262 Saishin et al. Jul 2002 B2
6423094 Sarfarazi Jul 2002 B1
6436092 Peyman Aug 2002 B1
6443985 Woods Sep 2002 B1
6450642 Jethmalani et al. Sep 2002 B1
6464725 Skotton Oct 2002 B2
6488708 Sarfarazi Dec 2002 B2
6493151 Schachar Dec 2002 B2
6503276 Lang et al. Jan 2003 B2
6517577 Callahan et al. Feb 2003 B1
6528602 Freeman et al. Mar 2003 B1
6551354 Ghazizadeh et al. Apr 2003 B1
6552860 Alden Apr 2003 B1
6554859 Lang et al. Apr 2003 B1
6585768 Hamano et al. Jul 2003 B2
6589550 Hodd et al. Jul 2003 B1
6592621 Domino Jul 2003 B1
6599317 Weinschenk et al. Jul 2003 B1
6601956 Jean et al. Aug 2003 B1
6610350 Suzuki et al. Aug 2003 B2
6616691 Tran Sep 2003 B1
6616692 Glick et al. Sep 2003 B1
6638304 Azar Oct 2003 B2
6638305 Laguette Oct 2003 B2
6638306 Cumming Oct 2003 B2
6645245 Preussner Nov 2003 B1
6645246 Weinschenk et al. Nov 2003 B1
6656223 Brady Dec 2003 B2
6660035 Lang et al. Dec 2003 B1
6692525 Brady et al. Feb 2004 B2
6695881 Peng et al. Feb 2004 B2
6709108 Levine et al. Mar 2004 B2
6712848 Wolf et al. Mar 2004 B1
6730123 Klopotek May 2004 B1
6743388 Sridharan et al. Jun 2004 B2
6749632 Sandstedt et al. Jun 2004 B2
6749634 Hanna Jun 2004 B2
6786934 Zadno-Azizi et al. Sep 2004 B2
6818158 Pham et al. Nov 2004 B2
6827738 Willis et al. Dec 2004 B2
6836374 Esch et al. Dec 2004 B2
6860601 Shadduck Mar 2005 B2
6878320 Alderson et al. Apr 2005 B1
6884261 Zadno-Azizi et al. Apr 2005 B2
6899732 Zadno-Azizi et al. May 2005 B2
6899850 Haywood et al. May 2005 B2
6914247 Duggan et al. Jul 2005 B2
6926736 Peng et al. Aug 2005 B2
6935743 Shadduck Aug 2005 B2
6949093 Peyman Sep 2005 B1
6966649 Shadduck Nov 2005 B2
6969403 Peng et al. Nov 2005 B2
7001374 Peyman Feb 2006 B2
7041134 Nguyen et al. May 2006 B2
7060094 Shahinpoor et al. Jun 2006 B2
7068439 Esch et al. Jun 2006 B2
7070276 Koretz Jul 2006 B2
7074227 Portney Jul 2006 B2
7122053 Esch Oct 2006 B2
7144423 Mcdonald Dec 2006 B2
7217288 Esch et al. May 2007 B2
7241312 Lai et al. Jul 2007 B2
7247168 Esch et al. Jul 2007 B2
7247689 Makker et al. Jul 2007 B2
7261737 Esch et al. Aug 2007 B2
7264351 Shadduck Sep 2007 B2
7276619 Kunzler et al. Oct 2007 B2
7278739 Shadduck Oct 2007 B2
7311194 Jin et al. Dec 2007 B2
7354451 Koch Apr 2008 B2
7378382 Serobian et al. May 2008 B2
7416300 Wei et al. Aug 2008 B2
7438723 Esch Oct 2008 B2
7452378 Zadno-Azizi et al. Nov 2008 B2
7453646 Lo Nov 2008 B2
7485144 Esch Feb 2009 B2
7494505 Kappelhof et al. Feb 2009 B2
7637947 Smith et al. Dec 2009 B2
7675686 Lo et al. Mar 2010 B2
7753953 Yee Jul 2010 B1
7759408 Schorzman et al. Jul 2010 B2
7763069 Brady et al. Jul 2010 B2
7776088 Shadduck Aug 2010 B2
7794498 Pinchuk Sep 2010 B2
7878655 Salvati et al. Feb 2011 B2
7971997 Hiramatsu et al. Jul 2011 B2
7988290 Campbell et al. Aug 2011 B2
7988292 Neal et al. Aug 2011 B2
7988293 Raymond et al. Aug 2011 B2
8048155 Shadduck Nov 2011 B2
8158712 Your Apr 2012 B2
8162927 Peyman Apr 2012 B2
8241355 Brady et al. Aug 2012 B2
8303656 Shadduck Nov 2012 B2
8314927 Choi et al. Nov 2012 B2
8328869 Smiley et al. Dec 2012 B2
8361145 Scholl et al. Jan 2013 B2
8377125 Kellan Feb 2013 B2
8425599 Shadduck Apr 2013 B2
8447086 Hildebrand et al. May 2013 B2
8454688 Esch et al. Jun 2013 B2
8480734 Kellan et al. Jul 2013 B2
8523941 Ichinohe et al. Sep 2013 B2
8574239 Ichinohe et al. Nov 2013 B2
8613766 Richardson et al. Dec 2013 B2
8632589 Helmy Jan 2014 B2
8668734 Hildebrand et al. Mar 2014 B2
8900298 Anvar et al. Dec 2014 B2
8956408 Smiley et al. Feb 2015 B2
8968396 Matthews et al. Mar 2015 B2
8992609 Shadduck Mar 2015 B2
9005282 Chang et al. Apr 2015 B2
9034035 Betser et al. May 2015 B2
9044317 Hildebrand et al. Jun 2015 B2
9277987 Smiley et al. Mar 2016 B2
9326846 Devita Gerardi et al. May 2016 B2
9329306 Huang et al. May 2016 B2
9456895 Shadduck Oct 2016 B2
9610155 Matthews Apr 2017 B2
9622855 Portney et al. Apr 2017 B2
9693858 Hildebrand et al. Jul 2017 B2
9795473 Smiley et al. Oct 2017 B2
9855137 Smiley et al. Jan 2018 B2
9855139 Matthews et al. Jan 2018 B2
9872762 Scholl et al. Jan 2018 B2
9872763 Smiley et al. Jan 2018 B2
10299913 Smiley et al. May 2019 B2
10357356 Smiley et al. Jul 2019 B2
10368979 Scholl et al. Aug 2019 B2
10390937 Smiley et al. Aug 2019 B2
10433949 Smiley et al. Oct 2019 B2
10433950 Shadduck Oct 2019 B2
10853373 Bhatia et al. Dec 2020 B1
11166808 Smiley et al. Nov 2021 B2
11484402 Smiley et al. Nov 2022 B2
20010001836 Cumming May 2001 A1
20010016771 Cumming Aug 2001 A1
20010039449 Johnson et al. Nov 2001 A1
20010051826 Bogaert et al. Dec 2001 A1
20020046783 Johnson et al. Apr 2002 A1
20020055777 Cumming et al. May 2002 A1
20020072795 Green Jun 2002 A1
20020095212 Boehm Jul 2002 A1
20020107568 Zadno-Azizi et al. Aug 2002 A1
20020111678 Zadno-Azizi et al. Aug 2002 A1
20020116057 Ting et al. Aug 2002 A1
20020116058 Zadno-Azizi et al. Aug 2002 A1
20020116059 Zadno-Azizi et al. Aug 2002 A1
20020116060 Nguyen et al. Aug 2002 A1
20020116061 Zadno-Azizi et al. Aug 2002 A1
20020133228 Sarver Sep 2002 A1
20020161434 Laguette et al. Oct 2002 A1
20020161435 Portney Oct 2002 A1
20020177896 Israel Nov 2002 A1
20020188351 Laguette Dec 2002 A1
20020193876 Lang et al. Dec 2002 A1
20030003295 Dreher et al. Jan 2003 A1
20030004569 Haefliger Jan 2003 A1
20030018384 Valyunin et al. Jan 2003 A1
20030042176 Alderson et al. Mar 2003 A1
20030050695 Lin et al. Mar 2003 A1
20030050696 Cumming Mar 2003 A1
20030060878 Shadduck Mar 2003 A1
20030060881 Glick et al. Mar 2003 A1
20030078656 Nguyen Apr 2003 A1
20030078657 Zadno-Azizi et al. Apr 2003 A1
20030078658 Zadno-Azizi Apr 2003 A1
20030083744 Khoury May 2003 A1
20030109925 Ghazizadeh et al. Jun 2003 A1
20030109926 Portney Jun 2003 A1
20030130732 Sarfarazi Jul 2003 A1
20030135272 Brady et al. Jul 2003 A1
20030149480 Shadduck Aug 2003 A1
20030158599 Brady et al. Aug 2003 A1
20030171808 Phillips Sep 2003 A1
20030183960 Buazza et al. Oct 2003 A1
20030187505 Liao Oct 2003 A1
20030199977 Cumming Oct 2003 A1
20030236376 Kindt-Larsen et al. Dec 2003 A1
20040001180 Epstein Jan 2004 A1
20040006386 Valint et al. Jan 2004 A1
20040006387 Kelman Jan 2004 A1
20040008419 Schachar Jan 2004 A1
20040015236 Sarfarazi Jan 2004 A1
20040039446 Mcnicholas Feb 2004 A1
20040054408 Glick et al. Mar 2004 A1
20040059343 Shearer et al. Mar 2004 A1
20040066489 Benedikt et al. Apr 2004 A1
20040082993 Woods Apr 2004 A1
20040082994 Woods et al. Apr 2004 A1
20040085511 Uno et al. May 2004 A1
20040085515 Roffman et al. May 2004 A1
20040088050 Norrby et al. May 2004 A1
20040111151 Paul et al. Jun 2004 A1
20040111152 Kelman Jun 2004 A1
20040111153 Woods et al. Jun 2004 A1
20040127984 Paul et al. Jul 2004 A1
20040162612 Portney et al. Aug 2004 A1
20040169816 Esch Sep 2004 A1
20040169932 Esch et al. Sep 2004 A1
20040181279 Nun Sep 2004 A1
20040184158 Shadduck Sep 2004 A1
20040230203 Yaguchi Nov 2004 A1
20050021139 Shadduck Jan 2005 A1
20050090612 Soane et al. Apr 2005 A1
20050113911 Peyman May 2005 A1
20050119740 Esch Jun 2005 A1
20050125000 Tourrette et al. Jun 2005 A1
20050131535 Woods Jun 2005 A1
20050149183 Shadduck Jul 2005 A1
20050165410 Zadno-Azizi et al. Jul 2005 A1
20050251253 Gross Nov 2005 A1
20050264755 Dietz Dec 2005 A1
20050264756 Esch Dec 2005 A1
20060041307 Esch et al. Feb 2006 A1
20060069433 Nun Mar 2006 A1
20060100701 Esch et al. May 2006 A1
20060100703 Evans et al. May 2006 A1
20060116763 Simpson Jun 2006 A1
20060134173 Liu et al. Jun 2006 A1
20060158611 Piers et al. Jul 2006 A1
20060183041 Erk et al. Aug 2006 A1
20060184181 Cole et al. Aug 2006 A1
20060200167 Peterson et al. Sep 2006 A1
20060241752 Israel Oct 2006 A1
20060253196 Woods Nov 2006 A1
20070004886 Schorzman et al. Jan 2007 A1
20070005136 Richardson Jan 2007 A1
20070021831 Clarke Jan 2007 A1
20070027538 Aharoni et al. Feb 2007 A1
20070050023 Bessiere et al. Mar 2007 A1
20070078515 Brady Apr 2007 A1
20070088433 Esch et al. Apr 2007 A1
20070100445 Shadduck May 2007 A1
20070106377 Smith et al. May 2007 A1
20070118216 Pynson May 2007 A1
20070129801 Cumming Jun 2007 A1
20070156236 Stenger Jul 2007 A1
20070162112 Burriesci et al. Jul 2007 A1
20070203578 Scholl et al. Aug 2007 A1
20070213817 Esch et al. Sep 2007 A1
20070244561 Ben Nun Oct 2007 A1
20070260157 Norrby Nov 2007 A1
20070299487 Shadduck Dec 2007 A1
20080004699 Ben Nun Jan 2008 A1
20080015689 Esch et al. Jan 2008 A1
20080027537 Gerlach et al. Jan 2008 A1
20080033449 Cole et al. Feb 2008 A1
20080035243 Breitenkamp et al. Feb 2008 A1
20080046074 Smith et al. Feb 2008 A1
20080046075 Esch et al. Feb 2008 A1
20080097460 Boukhny et al. Apr 2008 A1
20080139769 Iwamoto et al. Jun 2008 A1
20080179770 Rooney et al. Jul 2008 A1
20080188930 Mentak et al. Aug 2008 A1
20080200982 Your Aug 2008 A1
20080243247 Poley et al. Oct 2008 A1
20080269887 Cumming Oct 2008 A1
20080269987 Barron et al. Oct 2008 A1
20080300680 Joshua Dec 2008 A1
20080306587 Your Dec 2008 A1
20080306588 Smiley et al. Dec 2008 A1
20090005865 Smiley et al. Jan 2009 A1
20090027661 Choi et al. Jan 2009 A1
20090030425 Smiley et al. Jan 2009 A1
20090076602 Ho et al. Mar 2009 A1
20090124773 Zhou et al. May 2009 A1
20090149952 Shadduck Jun 2009 A1
20090228101 Zadno-Azizi Sep 2009 A1
20090234449 De Juan et al. Sep 2009 A1
20090248154 Dell Oct 2009 A1
20090264998 Mentak et al. Oct 2009 A1
20090281620 Sacharoff et al. Nov 2009 A1
20090292293 Bogaert et al. Nov 2009 A1
20090312836 Pinchuk et al. Dec 2009 A1
20090319040 Khoury Dec 2009 A1
20100016963 Park Jan 2010 A1
20100039709 Lo Feb 2010 A1
20100063588 Park Mar 2010 A1
20100069522 Linhardt et al. Mar 2010 A1
20100094412 Wensrich Apr 2010 A1
20100131058 Shadduck May 2010 A1
20100131061 Callahan et al. May 2010 A1
20100161049 Inoue Jun 2010 A1
20100179653 Argento et al. Jul 2010 A1
20100228344 Shadduck Sep 2010 A1
20100228346 Esch Sep 2010 A1
20100324671 Shadduck Dec 2010 A1
20100324672 Esch et al. Dec 2010 A1
20110052020 Hildebrand et al. Mar 2011 A1
20110118834 Lo et al. May 2011 A1
20110153015 Simonov et al. Jun 2011 A1
20110208301 Anvar et al. Aug 2011 A1
20110282442 Scholl et al. Nov 2011 A1
20110282443 Smiley et al. Nov 2011 A1
20110288638 Smiley et al. Nov 2011 A1
20110313522 Hayes Dec 2011 A1
20110313523 Hayes Dec 2011 A1
20120022547 Hildebrand et al. Jan 2012 A1
20120078361 Shadduck Mar 2012 A1
20120078363 Lu Mar 2012 A1
20120078364 Stenger Mar 2012 A1
20120116506 Compertore May 2012 A1
20120179249 Coleman Jul 2012 A1
20120221102 Tanaka et al. Aug 2012 A1
20120226351 Peyman Sep 2012 A1
20120245591 Matthews Sep 2012 A1
20120253458 Geraghty et al. Oct 2012 A1
20120253459 Reich et al. Oct 2012 A1
20120303119 Callahan et al. Nov 2012 A1
20120330415 Callahan et al. Dec 2012 A1
20130053954 Rao et al. Feb 2013 A1
20130060331 Shadduck Mar 2013 A1
20130103146 Smiley et al. Apr 2013 A1
20130128368 Costache et al. May 2013 A1
20130131794 Smiley et al. May 2013 A1
20130184816 Hayes Jul 2013 A1
20130250239 Hildebrand et al. Sep 2013 A1
20130268070 Esch et al. Oct 2013 A1
20130317607 Deboer et al. Nov 2013 A1
20140121768 Simpson May 2014 A1
20140142587 Walter et al. May 2014 A1
20140142588 Hildebrand et al. May 2014 A1
20140227437 Deboer et al. Aug 2014 A1
20140228949 Argento et al. Aug 2014 A1
20140249625 Shadduck Sep 2014 A1
20140257478 Mccafferty Sep 2014 A1
20140330375 Mccafferty Nov 2014 A1
20140336757 Simonov et al. Nov 2014 A1
20150087743 Anvar et al. Mar 2015 A1
20150202041 Shadduck Jul 2015 A1
20150238310 Matthews et al. Aug 2015 A1
20150257074 Bao et al. Sep 2015 A1
20150257874 Hildebrand et al. Sep 2015 A1
20160008126 Salahieh et al. Jan 2016 A1
20160038278 Matthews Feb 2016 A1
20160058553 Salahieh et al. Mar 2016 A1
20160106534 Deboer et al. Apr 2016 A1
20160113761 Nishi et al. Apr 2016 A1
20160128826 Silvestrini et al. May 2016 A1
20160128827 Zhao May 2016 A1
20160157996 Dolla et al. Jun 2016 A1
20160184089 Dudee et al. Jun 2016 A1
20160184091 Smiley et al. Jun 2016 A1
20160184092 Smiley et al. Jun 2016 A1
20160262875 Smith et al. Sep 2016 A1
20170020662 Shadduck Jan 2017 A1
20170049561 Smiley et al. Feb 2017 A1
20170079773 Matthews et al. Mar 2017 A1
20170258581 Borja et al. Sep 2017 A1
20170290658 Hildebrand et al. Oct 2017 A1
20180125640 Smiley et al. May 2018 A1
20180132997 Smiley et al. May 2018 A1
20180147051 Scholl et al. May 2018 A1
20180153682 Hajela et al. Jun 2018 A1
20180256315 Hildebrand et al. Sep 2018 A1
20180318066 Campin et al. Nov 2018 A1
20190240004 Smiley et al. Aug 2019 A9
20190358025 Smiley et al. Nov 2019 A1
20200000577 Smiley et al. Jan 2020 A1
20230016461 Smiley et al. Jan 2023 A1
Foreign Referenced Citations (93)
Number Date Country
1200659 Dec 1998 CN
1283974 Feb 2001 CN
1367667 Sep 2002 CN
1378440 Nov 2002 CN
1384727 Dec 2002 CN
101039635 Sep 2007 CN
101277659 Oct 2008 CN
102271622 Dec 2011 CN
202288610 Jul 2012 CN
0212616 Mar 1987 EP
0898972 Mar 1999 EP
1332731 Aug 2003 EP
1356791 Oct 2003 EP
1659991 May 2006 EP
2060243 May 2009 EP
2192934 Jun 2010 EP
2346441 Jul 2011 EP
2655841 Jun 1991 FR
2784575 Dec 2000 FR
02-167157 Jun 1990 JP
07-044938 May 1995 JP
08-501715 Feb 1996 JP
85-01715 Feb 1996 JP
08-224295 Sep 1996 JP
82-24295 Sep 1996 JP
09-294754 Nov 1997 JP
92-94754 Nov 1997 JP
10-206609 Aug 1998 JP
11-047168 Feb 1999 JP
1999-047168 Feb 1999 JP
11-056998 Mar 1999 JP
11056998 Mar 1999 JP
11-169391 Jun 1999 JP
11-276509 Oct 1999 JP
11-332903 Dec 1999 JP
11-47168 Sep 2000 JP
2001-502592 Feb 2001 JP
2003-144387 May 2003 JP
2003-524503 Aug 2003 JP
2003-530978 Oct 2003 JP
2006-341094 Dec 2006 JP
2007-513715 May 2007 JP
2007-518447 Jul 2007 JP
2008-531069 Aug 2008 JP
2008-534111 Aug 2008 JP
2008-307394 Dec 2008 JP
2009-034451 Feb 2009 JP
2009-511230 Mar 2009 JP
2010-520010 Jun 2010 JP
100807940 Feb 2008 KR
1810052 Apr 1993 RU
WO 1994007435 Apr 1994 WO
WO 1995002378 Jan 1995 WO
WO 1996025962 Aug 1996 WO
WO 1997006751 Feb 1997 WO
WO 1999003427 Jan 1999 WO
WO 2000041650 Jul 2000 WO
WO 2000064655 Nov 2000 WO
WO 2001060286 Aug 2001 WO
WO 2001089435 Nov 2001 WO
WO 2001097742 Dec 2001 WO
WO 2002051338 Jul 2002 WO
WO 2004010895 Feb 2004 WO
WO 2004046768 Jun 2004 WO
WO 2004052242 Jun 2004 WO
WO 2004054471 Jul 2004 WO
WO 2004072689 Aug 2004 WO
WO 2005018504 Mar 2005 WO
WO 2005084588 Sep 2005 WO
WO 2006004707 Jan 2006 WO
WO 2006011937 Feb 2006 WO
WO 2006014738 Apr 2006 WO
WO 2006047383 May 2006 WO
WO 2006088440 Aug 2006 WO
WO 2007005529 Jan 2007 WO
WO 2007005692 Jan 2007 WO
WO 2007030095 Mar 2007 WO
WO 2007047530 Apr 2007 WO
WO 2007061688 May 2007 WO
WO 2007128423 Nov 2007 WO
WO 2007138564 Dec 2007 WO
WO 2008108524 Sep 2008 WO
WO 2008108525 Sep 2008 WO
WO 2009100322 Aug 2009 WO
WO 2009154455 Dec 2009 WO
WO 2010081093 Jul 2010 WO
WO 2011119334 Sep 2011 WO
WO 2012006186 Jan 2012 WO
WO 2012129419 Sep 2012 WO
WO 2013070924 May 2013 WO
WO 2013142323 Sep 2013 WO
WO 2014095611 Jun 2014 WO
WO 2014152017 Sep 2014 WO
Non-Patent Literature Citations (66)
Entry
Baughman et al. “Negative poisson's ratios for extreme states fo matter,” Science, vol. 288, pp. 2018-2022, Jun. 16, 2000.
Baughman, “Avoiding the shrink,” Nature, vol. 425, pp. 667, Oct. 16, 2003.
Conlisk, A. T. et al. “Mass Transfer and Flow in Electrically Charged Micro-and Nano-channels,” Analytical Chemistry, vol. 74; iss. 9; pp. 2139-2150; May 2002.
Dubbelman et al. “The Thickness of the Aging Human Lens Obtained from Corrected Scheimpflug Images,” Optometry & Vision Science; vo. 78; iss. 6; pp. 411-416; Jun. 2001.
Gorder, P. F.; Electricity can pump medicine in implanted medical devices; Ohio State Research News; 3 pgs.; May 2, 2002 (printed from internet Aug. 19, 2010).
Gordon, “Applications of shape memory polyurethanes,” Proceedings of the First Intl Conf. on Shape Memory and Superelastic Tech., Asilomar Conference Center, Pacific Grove, CA, USA, pp. 115-120, Mar. 1994.
Gruber et al. “Exhaustive soxhlet extraction for the complete removal of residual compounds,” Journal of Biomedical Materials Research, vol. 53; No. 5; pp. 445-448; Mar. 2000.
Jeon et al., “Shape memory and nanostructure in poly(norbornyl-POSS) copolymers,” Polymer International, vol. 49, pp. 453-457, May 2000.
Kim et al., “Polyurethanes having shape memory effects,” Polymer, vol. 37, No. 26, pp. 5781-5793, Dec. 1996.
Lakes et al., “Dramatically stiffer elastic composite materials due to negative stiffness phase?,” Journal of the Mechanics and Physics of Solids, vol. 50, pp. 979-1009, May 2002.
Lakes et al., “Extreme damping in composite materials with negative-stiffness inclusions,” Nature, vol. 410, pp. 565-567, Mar. 29, 2001.
Lakes et al., “Microbuckling instability in elastomeric cellular sollids,” J. Materials Science, vol. 28, pp. 4667-4672, Jan. 1993.
Lakes, “A broader view of membranes,” Nature, vol. 414, pp. 503-504, Nov. 29, 2001.
Lakes, “Deformations in extreme matter,” Science; perspectives; vol. 288; No. 5473; pp. 1976-1977; Jun. 16, 2000.
Lakes, “Extreme damping in compliant composites with a negative-stiffness phase,” Philosophical Magazine Letters, vol. 81, No. 2, pp. 95-100, Feb. 2001.
Lakes, “Extreme damping in composite materials with a negative stiffness phase,” Physical Review Letters, vol. 86, No. 13, pp. 2897-2900, Mar. 26, 2001.
Lakes, “Negative poisson's ratio materials,” Science, vol. 238, pp. 551, Oct. 23, 1987.
Lakes, “No contractile obligations,” Nature, vol. 358, pp. 713-714, Dec. 31, 1992.
Langenbucher et al., “Computerized calculation scheme for toric intraocular lenses,” Acta Ophthalmologica Scandinavica, vol. 82, No. 3, pp. 270-276, Jun. 2004.
Lendlein et al., “Biodegradable, elastic shape-memory polymers for potential biomedical applications”, Science; vol. 296; pp. 1673-1676; May 31, 2002.
Lendlein et al., “Shape-memory polymers,” Angew. Chem. Int. Ed.; vol. 41; pp. 2034-2057; Jun. 2002.
Li et al., “Crystallinity and morphology of segmented polyurethanes with different soft-segment length,” Journal of Applied Polymer Science, vol. 62, pp. 631-638, Oct. 1996.
Liu et al., “Thermomechanical characterization of a tailored series of shape memory polymers,” Journal of Applied Medical Polymers, vol. 6, No. 2, Dec. 2002.
Mather et al., “Strain recovery in POSS hybrid thermoplastics,” Polymer Preprints, vol. 41, No. 1, pp. 528-529, Feb. 2000.
Metcalfe et al., “Cold hibernated elastic memory foams for endovascular interventions,” Biomaterials, vol. 24, pp. 491-497, Feb. 2003.
Qiao et al., Bio-inspired accommodating fluidic intraocular lens; Optics Letters; vol. 34; No. 20; pp. 3214-3216; Oct. 15, 2009.
Rosales et al., Pentacam Scheimpflug Quantitativelmaging of the Crystalline Lens andIntraocular Lens; J. Refractive Surgery; vol. 25; pp. 421-428; May 2009.
Takahashi et al., “Structure and properties of shape-memory polyurethane block copolymers,” Journal of Applied Polymer Science, vol. 60, pp. 1061-1069, May 1996.
Tehrani et al. “Capsule measuring ring to predict capsular bag diameter and follow its course after foldable intraocular lens implantation,” J Cataract Refract Surg.; vol. 29; No. 11; pp. 2127-2134; Nov. 29, 2003.
Tobushi et al., “Thermomechanical properties of shape memory polymers of polyurethane series and their applications,” Journal de Physique IV, Colloque C1, vol. 6, pp. 377-384, Aug. 1996.
Vass et al. “Prediction of pseudophakic capsular bag diameter based on biometric variables,” J Cataract Refract Surg.; vol. 25; pp. 1376-1381; Oct. 1999.
Wang et al., “Deformation of extreme viscoelastic metals and composites,” Materials Science and Enginerring A, vol. 370, pp. 41-49, Apr. 15, 2004.
Wang et al., “Extreme stiffness systems due to negative stiffness elements,” American Journal of Physics, vol. 72, No. 1, pp. 40-50, Jan. 2004.
Wang et al., “Stable extremely-high-damping discrete viscoelastic systems due to native stiffness elements,” Applied Physics Letters, vol. 84, No. 22, pp. 4451-4453, May 31, 2004.
Wyant et al; “Basic Wavefront Aberration Theory for Optical Metrology,” Applied Optics and Optical Engineering, vol. XI, pp. 1, 28-39, Aug. 10, 1992.
Xu et al., “Making negative poisson's ratio microstructures by soft lithography,” Advanced Materials, vol. 11, No. 14, pp. 1186-1189, Jun. 1999.
Lakes et al., “Microbuckling instability in elastomeric cellular solids,” J. Materials Science, vol. 28, pp. 4667-4672, Jan. 1993.
Langenbucher et al., “Computerized calculation scheme for toric intraocular lenses,” Acta Opthalmologica Scandinavica, vol. 82, No. 3, pp. 270-276, Jun. 2004.
Matthews et al.; U.S. Appl. No. 13/835,876 entitled “Intraocular Lens Delivery Systems and Methods of Use,” filed Mar. 15, 2013.
Matthews et al.; U.S. Appl. No. 14/637,171 entitled “Intraocular lens delivery systems and methods of use,” filed Mar. 3, 2015.
Matthews, Gregory V.; U.S. Appl. No. 13/427,617 entitled “Intraocular Lens Loading Systems and Methods of Use,” filed Mar. 22, 2012.
Rosales et al.; Pentacam Scheimpflug QuantitativeImaging of the Crystalline Lens andIntraocular Lens; J. Refractive Surgery; vol. 25; pp. 421-428; May 2009.
Tehrani et al. “Capsule measuring ring to predict capsular bag diameter and follow its course after foldable intraocular lens implantation,” J Cataract Refract Surg.; vol. 29; No. 11; pp. 2127-2134; Nov. 2003.
U.S. Appl. No. 10/971,598, filed Oct. 22, 2004.
U.S. Appl. No. 11/173,961, filed Jul. 1, 2005.
U.S. Appl. No. 11/252,916, filed Oct. 17, 2005.
U.S. Appl. No. 11/520,204, filed Sep. 12, 2006.
U.S. Appl. No. 11/642,388, filed Dec. 19, 2006.
U.S. Appl. No. 11/646,913, filed Dec. 27, 2006.
U.S. Appl. No. 11/715,221, filed Mar. 6, 2007.
U.S. Appl. No. 11/782,474, filed Jul. 24, 2007.
U.S. Appl. No. 11/844,087, filed Aug. 23, 2007.
U.S. Appl. No. 11/844,108, filed Aug. 23, 2007.
U.S. Appl. No. 12/177,857, filed Jul. 22, 2008.
U.S. Appl. No. 12/782,639, filed May 18, 2010.
U.S. Appl. No. 12/853,892, filed Aug. 10, 2010.
U.S. Appl. No. 13/193,487, filed Jul. 28, 2011.
U.S. Appl. No. 13/193,983, filed Jul. 29, 2011.
U.S. Appl. No. 13/194,004, filed Jul. 29, 2011.
U.S. Appl. No. 13/711,552, filed Dec. 11, 2012.
U.S. Appl. No. 13/909,946, filed Jun. 4, 2013.
U.S. Appl. No. 15/000,783, filed Jan. 19, 2016.
U.S. Appl. No. 15/064,482, filed Mar. 8, 2016.
U.S. Appl. No. 15/860,459, filed Jan. 2, 2018.
U.S. Appl. No. 15/870,673, filed Jan. 12, 2018.
U.S. Appl. No. 15/877,780, filed Jan. 23, 2018.
Related Publications (1)
Number Date Country
20210030530 A1 Feb 2021 US
Provisional Applications (1)
Number Date Country
60951441 Jul 2007 US
Continuations (4)
Number Date Country
Parent 15860459 Jan 2018 US
Child 17075522 US
Parent 13711552 Dec 2012 US
Child 15860459 US
Parent 12177857 Jul 2008 US
Child 13711552 US
Parent 11173961 Jul 2005 US
Child 11646913 US
Continuation in Parts (2)
Number Date Country
Parent 11782474 Jul 2007 US
Child 12177857 US
Parent 11646913 Dec 2006 US
Child 11782474 US